Taken together, the expression of GNPNAT1 was negatively associated with immune cell recruitment in BRCA, which possibly altered the composition of immune cells in the tumor environment and thereby affected the progression of BRCA patients. This evidence concerns the gene GNPNAT1 and invasive breast carcinoma.